[
  {
    "ticker": "NZK",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969962",
    "id": "02969962",
    "pages": 1,
    "price_sensitive": false,
    "date": "20250717",
    "time": "0731",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250717/pdf/06lvzx1n3wzfg4.pdf",
    "summary": "<ul>\n<li><strong>Balance Date Change</strong>: Shifted from 31 January to 30 September; next annual report covers 8 months to 30 September 2025.  </li>\n<li><strong>Revised EBITDA Guidance</strong>: $1M\u2013$7M (pro-forma) for shortened 8-month period ending 30 September 2025, consistent with 30 May 2025 update.  </li>\n<li><strong>Operational Context</strong>: Harvest reduced to rebuild biomass; feed rates now aligned with forecasts.  </li>\n</ul>\n<p><em>Omitted: Contact details, boilerplate.</em></p>",
    "usage": {
      "prompt_tokens": 598,
      "completion_tokens": 107,
      "total_tokens": 705,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-16T21:50:48.514545"
  },
  {
    "ticker": "PEB",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969959",
    "id": "02969959",
    "pages": 9,
    "price_sensitive": false,
    "date": "20250717",
    "time": "0730",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250717/pdf/06lvzprrpnq9q0.pdf",
    "summary": "<h3><strong>Capital Raising Announcement Summary</strong></h3>\n<ul>\n<li><strong>Structure</strong>: Placement + Share Purchase Plan (SPP)  </li>\n<li><strong>Placement Details</strong>:  </li>\n<li><strong>Amount</strong>: 150M new shares  </li>\n<li><strong>Price</strong>: NZD 0.10 per share (~AUD 0.093)  </li>\n<li><strong>Issue Date</strong>: 11 July 2025 (conditional on shareholder/regulatory approvals by this date)  </li>\n<li><strong>SPP Details</strong>:  </li>\n<li><strong>Maximum Issuance</strong>: 50M new shares  </li>\n<li><strong>Offer Price</strong>: Same as Placement (NZD 0.10)  </li>\n<li><strong>Max Acceptance</strong>: NZD 50,000 per eligible shareholder (NZ residents only)  </li>\n<li><strong>Timetable</strong>:  <ul>\n<li><strong>Open</strong>: 11 July 2025  </li>\n<li><strong>Close</strong>: 25 July 2025  </li>\n<li><strong>Results/Issue Date</strong>: 1 August 2025  </li>\n</ul>\n</li>\n<li><strong>Use of Proceeds</strong>: Fund growth in non-Medicare channels and regain Medicare coverage.  </li>\n</ul>\n<p><strong>No material changes to dividend policy or escrow restrictions noted.</strong></p>",
    "usage": {
      "prompt_tokens": 3078,
      "completion_tokens": 230,
      "total_tokens": 3308,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-16T21:50:39.802195"
  },
  {
    "ticker": "TWR",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969958",
    "id": "02969958",
    "pages": 3,
    "price_sensitive": false,
    "date": "20250717",
    "time": "0730",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250717/pdf/06lvzmmx6c4l07.pdf",
    "summary": "<p><strong>Substantial Holding Disclosure Summary:</strong><br />\n- <strong>Substantial holder:</strong> Forsyth Barr Investment Management Limited (FBIM)<br />\n- <strong>Class:</strong> Ordinary Shares (5.007% stake, 17,151,296 shares)<br />\n- <strong>Key changes (16 Mar 2025 \u2013 15 Jul 2025):</strong><br />\n  - <strong>Net purchases:</strong> 8,305,701 shares (on-market purchases of 12,068,660 vs. sales of 3,762,959)<br />\n  - <strong>Transfers:</strong> 400,829 shares moved into discretionary management (DIMS), 121,500 out</p>",
    "usage": {
      "prompt_tokens": 1081,
      "completion_tokens": 130,
      "total_tokens": 1211,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-16T21:51:21.103022"
  },
  {
    "ticker": "PEB",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969961",
    "id": "02969961",
    "pages": 5,
    "price_sensitive": false,
    "date": "20250717",
    "time": "0730",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250717/pdf/06lvztybqcyv8w.pdf",
    "summary": "<h3><strong>Capital Raising Announcement Summary</strong></h3>\n<ul>\n<li><strong>Type</strong>: Placement  </li>\n<li><strong>Total Securities Issued</strong>: 160,728,498 ordinary shares (PEB)  </li>\n<li><strong>Issue Price</strong>: NZD 0.10 per share (~AUD 0.091)  </li>\n<li><strong>Capital Raised</strong>: NZD 16,072,850 (~AUD 14.7m)  </li>\n<li><strong>Key Condition</strong>: Shareholder approval (voting at AGM on <strong>6/8/2025</strong>)  </li>\n<li><strong>Proposed Issue Date</strong>: <strong>13/8/2025</strong>  </li>\n<li><strong>Purpose</strong>: Fund growth in non-Medicare channels and regain Medicare coverage.  </li>\n</ul>\n<p><strong>Omitted</strong>: Routine legal/regulatory boilerplate, non-material fees.</p>",
    "usage": {
      "prompt_tokens": 1703,
      "completion_tokens": 156,
      "total_tokens": 1859,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-16T21:50:59.281966"
  },
  {
    "ticker": "PEB",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969960",
    "id": "02969960",
    "pages": 5,
    "price_sensitive": false,
    "date": "20250717",
    "time": "0730",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250717/pdf/06lvzrvk2pblfn.pdf",
    "summary": "<ul>\n<li><strong>Capital Raising Type</strong>: Non-cash issue of securities (shares in lieu of director fees)  </li>\n<li><strong>Total Securities Issued</strong>: 1,930,000 ordinary shares (PEB)  </li>\n<li><strong>Issue Price</strong>: NZD 0.10 per share (AUD equivalent consideration: ~176,255)  </li>\n<li><strong>Key Condition</strong>: Shareholder approval required for director fee pool increase (vote on 6/8/2025)  </li>\n<li><strong>Purpose</strong>: Conserve cash by compensating directors via equity instead of cash fees.  </li>\n<li><strong>Issue Date</strong>: 13/8/2025 (conditional on approval).  </li>\n<li><strong>Material Note</strong>: Shares rank equally with existing securities; no underwriting or escrow.  </li>\n</ul>\n<p><em>Omitted: Routine director remuneration details, tax logistics, and non-material procedural terms.</em></p>",
    "usage": {
      "prompt_tokens": 1923,
      "completion_tokens": 168,
      "total_tokens": 2091,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-16T21:51:10.683316"
  }
]